Physician profile
Kimberley D Walters
NPI 1598769093
$1,401.93
in general payments reported to CMS, 2019-2025
11 companies · $530 in 2025
The $530 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.03 · 2020: $29.59 · 2021: $27.26 · 2022: $270 · 2023: $230 · 2024: $234 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $994.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $993.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $426.71 | 2020-2025 | Tryptyr, Total30, Precision 1 |
| Tarsus Pharmaceuticals, INC. | $236.76 | 2024-2025 | Xdemvy |
| Notal Vision, INC. | $189.50 | 2022 | |
| Bausch & Lomb Americas INC. | $131.46 | 2022-2025 | Infuse, Vyzulta, Xiidra |
| Sun Pharmaceutical Industries INC. | $111.41 | 2023-2025 | Cequa |
| Optos, INC. | $81.03 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $55.56 | 2023 | Acuvue |
| Oyster Point Pharma, INC. | $53.71 | 2022-2023 | Tyrvaya |
| Harrow Eye, LLC | $49.50 | 2025 | Vevye |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $39.72 | 2020-2021 | |
| Thea Pharma INC. | $26.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberley Walters listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.